ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

131 hedge funds and large institutions have $829M invested in Intra-Cellular Therapies Inc. in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 19 closing their positions.

Holders
131
Holders Change
–
Holders Change %
0%
% of All Funds
3.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
41
Reduced
47
Closed
19
Calls
$30.8M
Puts
$21M
Net Calls
+$9.82M
Net Calls Change
+$5.83M

Top Buyers

1
PC
1
PointState Capital
New York
$39.3M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$24.1M
3
Citadel Advisors
3
Citadel Advisors
Florida
$24.3M
4
DFO
4
Duquesne Family Office
New York
$6.25M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$8.47M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$12.1M
2
BBA
2
Baker Bros. Advisors
New York
$0
3
SC
3
Samlyn Capital
New York
$13.8M
4
RPAM
4
Rhenman & Partners Asset Management
Sweden
$16.7M
5
BlackRock
5
BlackRock
New York
$79M
Name Market Value Shares Shares
Change 		Shares
Change %
WVP
151
Worth Venture Partners
New Jersey
– – – –
DAM
152
DLD Asset Management
New York
– – – –
3 4 5 6
7